New specification for steviol glycoside under evaluation by FSANZ
Australia
Aug 30, 2021
FSANZ is evaluating approval of a new specification for the steviol glycoside, rebaudioside I, produced by enzymatic bioconversion of stevia leaf extract. Bioconversion enzymes are derived from a genetically modified yeast strain, Pichia pastoris.
For further information (in English), click on the Link
USA /EU/ India/China/Japan - New Regulatory Norms Promulgated for Nutraceuticals and Dietary Supplements to Address the Challenges regarding Its Safety and Efficacy
USA
Sep 27, 2022
Around the World - Exploration of facilitators and barriers to the regulatory frameworks of dietary and herbal supplements: a scoping review
USA
Sep 15, 2022
Use of phosphatidylserine (soy) as a supplemental ingredient in foods
Canada
Sep 14, 2022
Standard on dietary supplements
Guatemala
Sep 09, 2022
Dietary Supplement Q&A Guide Update
Brazil
Sep 07, 2022
Guidelines for health supplement claims
Indonesia
Aug 29, 2022
Maximum level of contaminants in health supplements
Vietnam
Aug 29, 2022
Bill restricting minors access to weight loss supplements
USA
Aug 26, 2022
Grape seed extract as a supplemental ingredient in foods
Canada
Aug 24, 2022
Green tea extract as a supplemental ingredient in foods
Canada
Aug 18, 2022
South-east Asia / Europe - Review on Regulation of Herbal Products Used as a Medicine Across the Globe: A Case Study on Turmeric - Golden Medicine
European Union
Aug 18, 2022
Warning on the labeling of food supplements with curcuma
Italy
Aug 18, 2022
Amendment on Labeling Standards for Functional Health Foods
South Korea
Aug 17, 2022
EU - Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the EFSA Clock Stop Regarding Novel Food Authorisation
European Union
Aug 17, 2022
The Regulation of Dietary Supplements in the United States
USA
Aug 04, 2022
